The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by REUS, V. I.
* Articles by RAWITSCHER, L.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by REUS, V. I.
* Articles by RAWITSCHER, L.
Am J Psychiatry 157:839, May 2000
© 2000 American Psychiatric Association


Letter to the Editor

Possible Interaction of Tramadol and Antidepressants

VICTOR I. REUS, M.D., and LEE RAWITSCHER, M.D.
San Francisco, Calif.

Clinicians wishing to follow the recommendations of Toby D. Goldsmith, M.D., et al. (1) in using tramadol hydrochloride to achieve rapid remission of obsessive-compulsive disorder (OCD) should be advised that drug-drug interactions may result if concomitant antidepressant treatment is used. In the case presented in the letter by Dr. Goldsmith and colleagues, a patient with OCD was receiving fluoxetine, 20–40 mg/day, in addition to tramadol in the course of her treatment. The authors mention the possibility of a serotonin syndrome developing but do not discuss the risk for seizure, which may result from P450 inhibition induced by the selective serotonin reuptake inhibitor (SSRI), as well as competitive binding to the substrate. This is a documented warning in the Physicians’ Desk Reference, and patients receiving both types of medication should be fully informed of this possibility to minimize medical-legal risk.

REFERENCES

  1. Goldsmith TD, Shapira NA, Keck PE Jr: Rapid remission of OCD with tramadol hydrochloride (letter). Am J Psychiatry 1999; 156:660–661[Free Full Text]



This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
S. Perrot, R.-M. Javier, M. Marty, C. Le Jeunne, F. Laroche, and the CEDR (Cercle d'Etude de la Douleur en Rhumatol
Is there any evidence to support the use of anti-depressants in painful rheumatological conditions? Systematic review of pharmacological and clinical studies
Rheumatology, August 1, 2008; 47(8): 1117 - 1123.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. A. Jenike
Obsessive-Compulsive Disorder
N. Engl. J. Med., January 15, 2004; 350(3): 259 - 265.
[Full Text] [PDF]


This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by REUS, V. I.
* Articles by RAWITSCHER, L.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by REUS, V. I.
* Articles by RAWITSCHER, L.


Get information about faster international access.

Privacy Policy

Copyright © 2000 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org